A detailed history of Gf Fund Management Co. Ltd. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 19,514 shares of SMMT stock, worth $455,651. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,514
Previous 16,905 15.43%
Holding current value
$455,651
Previous $302 Million 24.78%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

BUY
$16.65 - $23.76 $43,439 - $61,989
2,609 Added 15.43%
19,514 $376 Million
Q4 2024

Feb 18, 2025

BUY
$17.52 - $23.46 $296,175 - $396,591
16,905 New
16,905 $302 Million

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $4.7B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.